Bioprotein Technologies
Biomanufacturing
2001
www.bioprotein.com
BioProtein Technologies is a contract manufacturing organization specializing in the production of human therapeutic proteins and vaccines in the milk of transgenic rabbits. The company can produce drugs from different classes (e.g. recombinant proteins, monoclonal antibodies, human growth hormones). It develops genetic constructs allowing for production of the desired drug by the animal. BioProtein Technologies' unique manufacturing capabilities are designed to provide pharmaceutical and biotechnology companies, as well as academic and research organizations, with the highest standard in recombinant protein & vaccine production.
Gilde acted as co-lead investor the first round of Financing and has supported the company in all its subsequent financing rounds.
